Image source: The Motley Fool. Mirum Pharmaceuticals (NASDAQ:MIRM) reported full-year revenue growth of 55%, driven by Livmarli uptake and strong bile acid medicine sales. A surge in R&D investment is ...

Microsoft's PC Manager promises to optimize your machine's performance at no cost. I tried it out to see if it's good enough to replace third-party tools.

The first payments for the Stay NJ property tax relief program are beginning to roll out. But with a price tag of about $1.2 billion each year, and guaranteed funding only through June of this year, ...

Farm management analyst Kent Thiesse answers some of the farm program and crop insurance questions that have resulted from the implementation of the One Big Beautiful Bill Act. Some of the farm ...

For 24 years, Microsoft’s Amanda Silver has been working to help developers — and in the last few years, that’s meant building tools for AI. After a long stretch on GitHub Copilot, Silver is now a ...

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a leading rare disease company, today announced the successful completion of its acquisition of Bluejay Therapeutics, a privately held biotechnology company ...

WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...

Corvette Racing will have a brand new program manager ahead of the 2026 racing season as Andrea Hidalgo steps up to the challenge. She replaces Jessica Dane, who recently left General Motors after ...

Ares Management CEO and co-founder Michael Arougheti joins 'Squawk on the Street' to discuss AI bubble concerns, private credit, and more. Got a confidential news tip? We want to hear from you. Sign ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced its entry into a definitive agreement to acquire Bluejay Therapeutics, a privately held biotechnology ...